About LEO Pharma
LEO Pharma is a company based in Copenhagen (Denmark) founded in 1908.. LEO Pharma has raised $560.38 million across 3 funding rounds from investors including Nordic Capital. LEO Pharma has completed 2 acquisitions, including Peplin and Timber Pharmaceuticals. LEO Pharma offers products and services including Dermatology Treatments. LEO Pharma operates in a competitive market with competitors including Incyte, Formation Bio, Arcutis, DermBiont and Evommune, among others.
- Headquarter Copenhagen, Denmark
- Stage Unicorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Leo Pharma A/S
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$560.38 M (USD)
in 3 rounds
-
Latest Funding Round
$1.54 M (USD), Private Equity Round
Mar 31, 2022
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Peplin
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LEO Pharma
LEO Pharma offers a comprehensive portfolio of products and services, including Dermatology Treatments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products for managing skin conditions through research-based solutions
Unlock access to complete
Unlock access to complete
Software Development Team
55 people
Senior Team
39 people
Human Resources and Administration
37 people
Leadership Team
36 people
Finance and Accounting
36 people
Sales and Marketing
34 people
Product Management Team
15 people
Head Team
14 people
Unlock access to complete
Funding Insights of LEO Pharma
LEO Pharma has successfully raised a total of $560.38M across 3 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $1.54 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Private Equity Round — $1.5M
-
First Round
First Round
(12 Oct 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Private Equity Round - LEO Pharma | Valuation |
investors |
|
| Mar, 2021 | Amount | Private Equity Round - LEO Pharma | Valuation | Nordic Capital |
|
| Oct, 2009 | Amount | Series A - LEO Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in LEO Pharma
LEO Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Nordic Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by LEO Pharma
LEO Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Peplin and Timber Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for dermatological rare diseases are developed.
|
2011 | ||||
|
Topical gel for the treatment of actinic (solar) keratosis.
|
1999 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - LEO Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Leo Pharma Comparisons
Competitors of LEO Pharma
LEO Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Incyte, Formation Bio, Arcutis, DermBiont and Evommune, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
|
| domain | founded_year | HQ Location |
Immunotherapeutic solutions for dermatological conditions are developed.
|
|
| domain | founded_year | HQ Location |
Microbial therapeutics for skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic options for chronic inflammatory disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Leo Pharma
Frequently Asked Questions about LEO Pharma
When was LEO Pharma founded?
LEO Pharma was founded in 1908 and raised its 1st funding round 101 years after it was founded.
Where is LEO Pharma located?
LEO Pharma is headquartered in Copenhagen, Denmark.
Who is the current CEO of LEO Pharma?
Christophe Bourdon is the current CEO of LEO Pharma.
Is LEO Pharma a funded company?
LEO Pharma is a funded company, having raised a total of $560.38M across 3 funding rounds to date. The company's 1st funding round was a Series A of $22.76M, raised on Oct 12, 2009.
What does LEO Pharma do?
Developer of drugs for treating dermatology diseases. It offers variety of medicines such as topical creams and ointments, oral tablets, and injectable biologics for the treatment of psoriasis, eczema, and rare diseases. The pipeline products include Tralokinumab for atopic dermatitis and Delgocitinib a topical pan-JAK inhibitor for chronic hand eczema.
Who are the top competitors of LEO Pharma?
LEO Pharma's top competitors include Formation Bio, Arcutis and Incyte.
What products or services does LEO Pharma offer?
LEO Pharma offers Dermatology Treatments.
How many acquisitions has LEO Pharma made?
LEO Pharma has made 2 acquisitions, including Peplin, and Timber Pharmaceuticals.
Who are LEO Pharma's investors?
LEO Pharma has 1 investor. Key investors include Nordic Capital.
What is LEO Pharma's valuation?
The valuation of LEO Pharma is $2.28B as of Mar 2022.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.